Deutsche Bank’s TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK TRIV Stock Holding History

Deutsche Bank’s Portfolio TRIV Stock Details TRIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-4,540	Closed	-$30K	–	5561
2015 Q4	$30K	Sell	4,540 -60	-1%	-$398	﹤0.01%	4627
2015 Q3	$23K	Sell	4,600 -22,754	-83%	-$122K	﹤0.01%	4749
2015 Q2	$144K	Buy	27,354 +27,353	+2,735,300%	+$194K	﹤0.01%	4052
2015 Q1	$0	Sell	1 -715	-100%	-$7.37K	﹤0.01%	6378
2014 Q4	$9K	Buy	716 +647	+938%	+$8.82K	﹤0.01%	5755
2014 Q3	$0	Sell	69 -1,428	-95%	-$20.7K	﹤0.01%	6301
2014 Q2	$23K	Buy	+1,497	New	+$22.7K	﹤0.01%	5279

Deutsche Bank's TRIV Position: Q1 2016 in Review

Deutsche Bank sold out of TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK (TRIV) in Q1 2016, closing a stake of 4,540 shares — an estimated $30K sold.

Deutsche Bank first reported a position in TRIV in Q2 2014 and held it in 7 quarters. The position peaked at $144K in Q2 2015. 0 funds tracked by Wall St. Rank hold TRIV as of Q1 2016.

Deutsche Bank reported no remaining TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK position as of Q1 2016 after selling out during the quarter.
Deutsche Bank sold 4,540 TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK shares in Q1 2016, an estimated $30K.
Deutsche Bank first reported a position in TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK in Q2 2014 and held it in 7 quarters.
Deutsche Bank's TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK position peaked at $144K in Q2 2015.
0 funds tracked by Wall St. Rank held TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK as of Q1 2016.

Based on Deutsche Bank's 13F filing for Q1 2016, filed 16 May 2016.